Skip to content

Episode Notes

Source / episode info

  • Episode: 440
  • Title: Divine Intervention Episode 440: High Dose Dexamethasone (New USMLE Perspective)
  • Published: 2023-02-03
  • Source: Episode page

One-liner

This episode provides a critical update on Cushing's syndrome workup, emphasizing that while classic testing differentiates pituitary adenoma from ectopic sources, adrenal adenomas present a unique diagnostic challenge because their low baseline ACTH prevents cortisol suppression with any dose of dexamethasone.

High-yield summary

  • Initial Screening: The diagnosis requires measuring 24-hour urinary cortisol or late-night salivary cortisol to confirm hypercortisolism.
  • ACTH Status is Key: Measure baseline ACTH first to differentiate between ACTH-dependent (high ACTH) and ACTH-independent (low ACTH) Cushing's syndrome.
  • Pituitary vs Ectopic: In ACTH-dependent cases, high-dose dexamethasone suppression test (HDDST) typically suppresses cortisol in Cushing's disease (pituitary adenoma), but fails to suppress it when the source is ectopic (e.g., Small Cell Lung Cancer).
  • Adrenal Adenoma Trap: If the hypercortisolism is ACTH-independent due to an adrenal adenoma, the baseline ACTH will be suppressed, meaning neither low nor high-dose dexamethasone can induce cortisol suppression.
  • Clinical Correlation: High ACTH levels (ACTH-dependent) lead to skin hyperpigmentation because ACTH shares a precursor molecule with Melanocyte Stimulating Hormone (MSH).

Learning objectives

  • To perform the appropriate screening tests for hypercortisolism (e.g., 24h urinary free cortisol, late-night salivary cortisol).
  • To differentiate between Cushing's disease (pituitary adenoma), ectopic ACTH syndrome, and adrenal adenoma based on baseline ACTH levels and suppression test results.
  • To understand the molecular basis of hyperpigmentation in ACTH-dependent Cushing's syndrome via POMC/MSH.
  • To recognize that an autonomously functioning adrenal tumor will suppress pituitary ACTH, rendering dexamethasone suppression tests non-diagnostic.
  • To interpret the differential response to high vs. low doses of dexamethasone across various sources of excess ACTH.

Board exam buzzwords

ConditionKey FindingAssociationBoard Exam Tip
Cushing's SyndromeElevated 24h urinary cortisol / Late-night salivary cortisolInitial screening testAlways confirm hypercortisolism before proceeding to differentiation tests.
Pituitary Adenoma (Cushing's Disease)High ACTH, Suppresses with high-dose dexamethasonePOMC precursor moleculeRemember the classic response: pituitary tumors are often responsive to high doses of glucocorticoids.
Adrenal AdenomaLow ACTH, No suppression with any dose of DexamethasoneNegative feedback loop (high cortisol)This is a major trap! If ACTH is low, nothing will suppress it.
Small Cell Lung Cancer (SCLC)High ACTH, Does not suppress with high-dose dexamethasoneEctopic source; autonomous productionSCLC represents the most common cause of ectopic ACTH syndrome and does not respond to suppression tests.

Rapid review table

TopicKey PointContextExam Relevance
Cushing's Screening24h urinary free cortisol or late-night salivary cortisol > cutoffInitial diagnosis of hypercortisolismEstablishes the presence of Cushing's syndrome.
ACTH DependencyHigh ACTH suggests pituitary/ectopic source; Low ACTH suggests adrenal adenomaDifferentiating the cause of excess cortisolDetermines which diagnostic pathway (DST vs. imaging) to follow.
Dexamethasone ResponsePituitary tumor suppresses with high dose; Ectopic sources do not suppress.High-dose DST interpretationCrucial for distinguishing Cushing's disease from ectopic ACTH syndrome.
Adrenal Adenoma TrapLow baseline ACTH means no suppression occurs regardless of dexamethasone dose.Interpreting the HDDST in adrenal pathologyThe most common pitfall; always check baseline ACTH first!

Board-speak -> diagnosis

Board-speak / Vignette phraseDiagnosis / ConceptWhy it fits
A patient presents with Cushing's syndrome and has markedly elevated baseline ACTH, along with diffuse hyperpigmentation.ACTH-dependent Cushing's Syndrome (e.g., Pituitary or Ectopic)High ACTH drives MSH precursor production (POMC), causing melanocyte stimulation.
A patient with suspected pituitary adenoma undergoes HDDST and shows suppression of cortisol levels the next morning.Cushing's Disease (Pituitary Adenoma)The pituitary tumor is responsive to high doses of glucocorticoids, unlike ectopic sources.
A patient presents with hypercortisolism but has a normal adrenal gland that autonomously overproduces cortisol, leading to suppressed ACTH.Adrenal Adenoma / ACTH-independent Cushing's SyndromeHigh circulating cortisol exerts negative feedback on the pituitary/hypothalamus, suppressing ACTH production.
The initial workup of hypercortisolism is positive for elevated 24-hour urinary free cortisol levels.Screening for HypercortisolismThis establishes the presence of Cushing's syndrome before further differentiation tests are performed.
A patient with suspected ectopic ACTH source (e.g., SCLC) fails to suppress cortisol after receiving high-dose dexamethasone.Ectopic ACTH SyndromeThe tumor is autonomous and does not respond to exogenous glucocorticoid suppression, unlike a pituitary adenoma.
When evaluating Cushing's syndrome, the initial step must be measuring baseline ACTH levels.Differentiating ACTH DependencyThis determines if the source of excess cortisol is adrenal (low ACTH) or pituitary/ectopic (high ACTH).

Differential diagnosis / distinguishing features

Adrenal Adenoma vs Pituitary/Ectopic Sources

Key FeaturesDistinguishing FindingsNext Step
Adrenal AdenomaLow ACTH, No suppression with any dose of dexamethasone (due to negative feedback).Image the adrenal gland (CT) to confirm adenoma and plan for removal.
Pituitary/Ectopic SourcesHigh ACTH, Suppression pattern dictates source (responsive vs non-responsive).Perform HDDST and correlate findings with clinical picture.

Management pearls

  • Initial Workup: Always start by confirming hypercortisolism using 24h urinary free cortisol or late-night salivary cortisol before proceeding to differentiation tests.
  • ACTH Measurement: Measuring baseline ACTH is mandatory; it dictates whether the source is adrenal (low ACTH) or pituitary/ectopic (high ACTH).
  • HDDST Interpretation: Remember that a failure to suppress with high-dose dexamethasone points toward an ectopic source, while suppression suggests Cushing's disease.
  • Adrenal Adenoma Pitfall: If the patient has low baseline ACTH, do not rely on the HDDST; it will be non-suppressive regardless of dose due to negative feedback from the adrenal tumor itself.

Don't miss

🚨
The precursor molecule for both ACTH and MSH is Proopiomelanocortin (POMC) .
🚨
High ACTH levels lead to increased POMC cleavage, resulting in excess MSH components, causing skin hyperpigmentation.
🚨
Cushing's syndrome diagnosis requires ruling out other causes of cortisol excess; the pattern of suppression testing helps localize the source.
🚨
The adrenal adenoma scenario is a critical trap: low baseline ACTH means no dexamethasone dose will cause suppression.

Integration & clinical reasoning

  • Endocrinology/Oncology: Understanding this differential is crucial because the underlying pathology (e.g., SCLC) requires specific oncological management, not just pituitary surgery.
  • Physiology: The entire workup hinges on understanding negative feedback loops: high cortisol suppresses ACTH, and the responsiveness of the pituitary gland to exogenous glucocorticoids differentiates adenoma types.
  • Clinical Reasoning: Always integrate clinical signs (e.g., hyperpigmentation) with lab results (ACTH level) before interpreting suppression test outcomes.

Concept connections / cross-references

  • No explicit cross-references.

High-yield association table

ConditionAssociationMechanismClinical Significance
Cushing's SyndromeHypercortisolismExcess cortisol production from adrenal, pituitary, or ectopic source.Requires systematic workup using screening tests (24h UFC).
ACTH-dependent CSHyperpigmentationHigh ACTH stimulates POMC cleavage into MSH components.A strong clinical clue pointing toward high ACTH levels.
Cushing's DiseaseSuppression with HDDSTPituitary adenoma cells are responsive to high doses of glucocorticoids.Helps differentiate it from autonomous ectopic sources.
Adrenal AdenomaLow baseline ACTHAutonomous cortisol production causes negative feedback on the pituitary gland.Leads to a non-suppressive pattern regardless of dexamethasone dose.

Key terms glossary

TermDefinitionContextExample
POMC (Proopiomelanocortin)A precursor prohormone that is cleaved into multiple bioactive peptides.ACTH and MSH are derived from POMC cleavage.High ACTH levels lead to increased POMC processing.
ACTH (Adrenocorticotropic Hormone)Hormone stimulating the adrenal cortex to produce cortisol.Levels determine if Cushing's source is pituitary/ectopic or adrenal.Elevated ACTH suggests a problem upstream of the adrenal gland.
MSH (Melanocyte Stimulating Hormone)Peptide that stimulates melanocytes in the skin.Derived from POMC; its excess causes hyperpigmentation.Darkening of palmar creases and skin folds is characteristic of high ACTH states.
HDDST (High-Dose Dexamethasone Suppression Test)A diagnostic test where cortisol levels are measured after administering a high dose of dexamethasone.Used to differentiate Cushing's disease from ectopic sources.Failure to suppress suggests an autonomous, non-pituitary source.

Study optimization

TopicStudy ApproachPriorityResources
Cushing's Workup AlgorithmFlowchart approach: Screen -> Measure ACTH -> Interpret DST/Imaging.High (Board-level algorithm)Review board question banks focusing on endocrine differentials.
Molecular Basis of CSMemorize POMC -> ACTH + MSH pathway and the resulting hyperpigmentation.Medium (Conceptual understanding)Flashcards linking high ACTH to skin changes.
Pitfall RecognitionCreate a decision tree for the three sources: Pituitary, Ectopic, Adrenal Adenoma.Critical (High-yield trap material)Practice questions that force you to consider baseline ACTH first.

Question pattern recognition

  • Clinical Clue: Skin hyperpigmentation + Cushing's syndrome -> Highly suggests high ACTH levels and an ACTH-dependent source.
  • Lab Pattern: Hypercortisolism + Low baseline ACTH + No suppression with HDDST -> Classic presentation of Adrenal Adenoma (ACTH-independent).
  • Diagnostic Trap: If a patient has hypercortisolism, always check the baseline ACTH level first; this single test dictates whether you proceed to DST or adrenal imaging.

Test yourself

Common mistakes to avoid

🚫
Mistake 1: Assuming all Cushing's sources cause hyperpigmentation. Only ACTH-dependent causes do, due to the shared POMC precursor molecule with MSH.
🚫
Mistake 2: Interpreting non-suppression as always being ectopic. Non-suppression can also occur in adrenal adenoma because of negative feedback (low baseline ACTH).
🚫
Mistake 3: Confusing low-dose and high-dose dexamethasone effects. Low dose failure to suppress is characteristic of Cushing's disease, but the high dose test is often used for definitive differentiation from ectopic sources.

Common traps

⚠️
Trap 1 (The Adrenal Adenoma Trap): If ACTH is low at baseline, do not waste time interpreting suppression tests; they will fail regardless of the dexamethasone dose due to negative feedback.
⚠️
Trap 2 (The Ectopic vs Pituitary Trap): Remember that while both are high ACTH, only pituitary adenomas typically show suppression with high doses of dexamethasone.
⚠️
Trap 3 (The Hyperpigmentation Trap): Always link hyperpigmentation to the precursor molecule POMC and its cleavage into MSH components; this is a direct indicator of high ACTH/MSH activity.

Original transcript with highlights

Original transcript with highlights

All right, welcome. My name is divine. Welcome to today's episode of the Divine Intervention Podcasts. And this is actually going to be a really short episode. But it's something that I've seen so many people get wrong. And I just don't want many students to keep falling into this conundrum. So it's something I want to fix and fix today. So to this podcast is going to be titled the high-dose Dexamethasone Suppression Test. The high-dose Dexamethasone Suppression Test. I know some of you may be like, the divine command. I know about this. Cushing's disease and ectopic ac TH production. Boohoo. Don't talk to me. You're gonna see that there's actually a new angle that our friends at the endgame is take. Many resources either don't emphasize it or when they do, to be honest with you, many resources don't emphasize it. Or if people teach you they teach you wrong. So that's one thing I absolutely want to correct today. And again, if you're taking any of your USMEL exams, I have a step one review class that starts next week Thursday. And then I have a step two and step three review class, you know, biostatistics bootcamp, an MBA in testing and strategies class, and a social sciences quality improvement healthcare system and communications review taking place later this month. So if you're interested, shoot me an email through the website.

So, classically, people have learned the high-dose Dexamethasone Suppression Test as something that you do when a person is deemed to have an ac TH dependent cause of Cushing's syndrome, right? Because when a person has Cushing's syndrome, you can do one of three things. You can check the 24 hour urinary cortisol or you can check the lead night salivary cortisol or you can do a load those Dexamethasone Suppression Test and you'll notice that, wow, the next morning, the cortisol does not suppress. Do who? Okay. And then, so that's the usual algorithm people learn and then they go to step two, they're like, okay, let's measure ac TH to delineate between ac TH dependent Cushing's syndrome and ac TH dependent Cushing's syndrome. Obviously, if the ac TH is low, then you're like, oh, this is an ac TH independent cause of Cushing's syndrome. So it's like an adrenal adenoma that's pumping out a ton of cortisol. But if the ac TH is higher, you're like, oh, this is ac TH dependent. So the person's hypercord is all of them is being driven by increased ac TH production. And typically on exams, the thing you're trying to differentiate between in that case is a topic ac TH production from small cell lung cancer and Cushing's disease, which is a pituitary adenoma that's making a ton of ac TH.

And many people have learned that, oh, when you give high dose Dexamethasone, it will suppress the cortisol when a person has Cushing's disease, but it will not suppress the cortisol when a person has a topic ac TH production. And that is true. That makes perfect sense. Again, why does that make sense for people that are not very familiar with that? The reason that makes sense is the following. If you think about it, when a person has, when a person has like, you know, you have a normal anterior pituitary, a normal anterior pituitary should respond to low dose Dexamethasone. But when you obstig yourself to an adenoma, well, an adenoma just doesn't work as well as it should. Although an adenoma is not full blown cancer. So since it's an adenoma, you just need a little more Dexamethasone that is normal to whip it into shape. So that's why when you go with low dose Dexamethasone for Cushing's disease, it does not suppress the cortisol. When you try high dose Dexamethasone, it will suppress the cortisol. Now, another thing to also keep in mind is when you're dealing with small cell lung cancer, since it's cancer, it's not even an adenoma. It's like a full blown cancer. Full blown cancers don't really respond very well to normal signals. So even if you obstig the dose of Dexamethasone and give them a very high dose of Dexamethasone, it's not going to make any difference.

That's why in a topic, ACTH production from small cell lung cancer, you're going to notice that cortisol does not suppress. Okay, so that's the general knowledge that people have. I just thought I'll give a quick brief overview. Now, I want to establish something with Dexamethasone. Dexamethasone is not going to alter your cortisol response if your ACTH is already suppressed. I'll say that again. Dexamethasone will not alter your cortisol response if your ACTH is already suppressed. So as a corollary to that, the only time that Dexamethasone can affect your cortisol levels, especially high dose Dexamethasone, is when your ACTH is high at baseline before the study. I'll say that again, the only time high dose Dexamethasone will really affect your cortisol response is when your ACTH before the test is already high at baseline. Why am I saying this? Look at the name of the test. High dose Dexamethasone suppression. You're using high dose Dexamethasone to suppress something. So that means before you start the test, that thing is not suppressed. That thing is elevated. So with high dose Dexamethasone, you're only going to see anything if the ACTH is high at baseline. So with all this said, what is the new angle that our friends at the NBM is take? Well, the new angle is this angle of people having ACTH independent Cushing syndrome. When a person has ACTH independent Cushing syndrome, they have like an adrenaline at the normal, that is autonomously pumping out a ton of cortisol.

That cortisol is going to exert negative feedback on the hypothalamus and on the anterior pituitary. Your corticotropic relicin hormone is going to go down. Your ACTH is also going to go down as well. So your ACTH just by virtue of the pathology you have is going to be suppressed. I'll say that again. Your ACTH just by virtue of the pathology you have is going to be suppressed. So think about it. If your ACTH is already suppressed, is any change going to happen when you give high dose Dexamethasone? No. Because your ACTH, like the thing that Dexamethasone is supposed to suppress, is already suppressed. So there is not much that Dexamethasone can do in those circumstances. It's a subtle point, but it's a very important point to know for exams. It's a very important point that pops up a lot these days on exams. Many people screw this up. You don't have to be one of those people. You literally do not have to be one of those people. So again, please I'm begging, begging, begging you from the bottom of my heart. When a person has an adrenalinoma that is overproducing cortisol, aka they have an ACTH independent cause of their pushing syndrome. You need to know that those people, their cortisol will also not suppress with high dose Dexamethasone. So it doesn't matter what the dose of Dexamethasone is. Low dose Dexamethasone, high dose Dexamethasone, it literally does not matter. It literally does not matter. Those people's cortisol will not suppress. Why?

Because their ACTH at baseline is already suppressed. So there is literally nothing for high dose Dexamethasone or low dose Dexamethasone to suppress in the first place. That's very important. Like I'm telling you our friends at the USMEL is these days. They've been kind of throwing out questions where they'll say oh the person's cortisol does not suppress with low and high dose Dexamethasone. And one of the answers they'll throw in there in the question is they'll put small cell lung cancer. And then another answer they'll slot in in the question is adrenalinoma. And then the answer ends up being adrenalinoma. People are like how can be answered by adrenalinoma. No that's not possible. Yes it is possible. It is absolutely possible. So so people may be like okay divine. So if they give me a question where they say low and high dose Dexamethasone does not suppress the cortisol. What am I supposed to do? What am I supposed to do? The thing you're supposed to do is to either find the ACTH level in the question because obviously the ACTH will be low in in ACTH independent Cushing syndrome. And the ACTH is going to be high in an ACTH dependent Cushing syndrome. Alternatively the skin findings can be your clue. If the person has skin hyperpigmentation then that tells you that it's ACTH dependent Cushing syndrome. But if the person does not have skin hyperpigmentation that tells you that it's ACTH independent Cushing syndrome. Again why does that make any sense?

There isn't that makes any sense is that when you have ACTH dependent Cushing syndrome your ACTH is high. Well the thing is ACTH does not just fall out of the sky. No. ACTH is made from an ancestral molecule known as POMC. What is POMC stands for POMC stands for pro opiol melanocortin. Pro opiol melanocortin. So pro pro means is a precursor to something. Opio opio means opioid. In this case is betaendorphine which is a muagulis. Betaendorphine is one of the endogenous opioids we make in the brain. Remember the other endogenous opioids are like things like encephaline that work on delta receptors and the endorphine that works on copper receptors. But that's a step one concept also you know you see it on step two step three but anyhow but that's not the main focus so pro opiol melanocortin. Pro opiol opiol opioid that's betaendorphine melanoc that's MSH. Melanocystimulating hormone. Quartin that's ACTH. So whenever a person has high ACTH they're going to have skin hyperpigmentation. So if they give you a Cushing syndrome question and the person has skin hyperpigmentation that tells you right off the bat that this is an ACTH dependent cause of Cushing syndrome. It's an ACTH dependent cause of Cushing syndrome. ACT dependent so the ACTH is high so the MSH was behind so that's the same little melanocytes to give you that skin hyperpigmentation.

So again I'm going to go ahead and stop here please I am really really begging you this sounds like a benign podcast but I promise you it is not. I absolutely promise you this is not a benign podcast. So thank you for listening to me I'll see you in episode 441. Bye for now God bless you. Thank you. And by the way you know I also again offered to you during fall the US ML exams step one to three and I help with personal statements here as applications and whatnot and then I have these podcasts apps on my web I have this podcast on the podcast apps Spotify Google Apple and also have a You Tube channel. Dividing intervention US ML podcasts and videos and then also have a website divided intervention life lessons.com where post life lessons I post about two every week based on the Bible to help you address some life problems. So thank you. I'll see you next time. Bye for now again.

Practice questions — USMLE style

Question 1 — Endocrinology

A 45-year-old woman presents with signs of Cushing's syndrome, including proximal muscle weakness and striae. Initial testing reveals elevated cortisol levels. Subsequent measurement of ACTH is also high. To differentiate between a pituitary adenoma (Cushing's disease) and ectopic ACTH production from small cell lung cancer (SCLC), the physician orders a high-dose dexamethasone suppression test (HDDST). The patient’s morning cortisol level fails to suppress significantly after receiving high-dose dexamethasone, while her baseline ACTH remains elevated. Which of the following best explains this pattern?

  • A) Ectopic ACTH production from SCLC is resistant to glucocorticoid negative feedback due to its malignant nature.
  • B) The pituitary adenoma has become refractory to exogenous steroids, requiring a higher dose for suppression.
  • C) High-dose dexamethasone only suppresses cortisol when the adrenal glands are functioning normally and independently of ACTH stimulation.
  • D) The patient's hypercortisolism is primarily due to an adrenal tumor that is autonomously producing cortisol, thus suppressing endogenous ACTH.

Answer: A. Ectopic ACTH production from SCLC is resistant to glucocorticoid negative feedback due to its malignant nature. Explanation: Classically, in Cushing's syndrome with high ACTH, the HDDST helps differentiate causes. Pituitary adenomas (Cushing's disease) typically show suppression of cortisol upon administration of high-dose dexamethasone because they are still somewhat responsive to steroids. However, ectopic sources like SCLC produce ACTH via mechanisms that are often resistant to negative feedback from exogenous glucocorticoids, leading to non-suppression.

Question 2 — Endocrinology

A 58-year-old man is diagnosed with Cushing's syndrome secondary to an adrenal adenoma (ACTH-independent). He presents with elevated cortisol levels but has a suppressed ACTH level due to negative feedback from the excess cortisol. The physician performs a high-dose dexamethasone suppression test. Despite receiving a very high dose of dexamethasone, the patient’s morning cortisol remains significantly elevated and fails to suppress. What is the primary reason for the lack of cortisol suppression in this specific clinical scenario?

  • A) The adrenal adenoma has developed resistance to glucocorticoid effects, requiring an alternative diagnostic test.
  • B) High-dose dexamethasone cannot cross the adrenal gland membrane effectively when ACTH levels are suppressed.
  • C) Since the baseline ACTH level is already suppressed by the hypercortisolism, there is no stimulus for high-dose dexamethasone to suppress.
  • D) The patient's primary pathology is due to an opioid excess, which interferes with the hypothalamic-pituitary axis response to steroids.

Answer: C. Since the baseline ACTH level is already suppressed by the hypercortisolism, there is no stimulus for high-dose dexamethasone to suppress. Explanation: This is a critical concept taught in the podcast. The HDDST only works if the ACTH is elevated at baseline (ACTH-dependent Cushing's). If the cause of hypercortisolism is adrenal (ACTH-independent), the resulting high cortisol exerts negative feedback, suppressing endogenous ACTH production. Because the pituitary signal (ACTH) is already suppressed, administering dexamethasone has no measurable effect on the cortisol level.

Question 3 — Endocrinology

A patient with suspected Cushing's syndrome presents to the clinic. Physical examination reveals marked skin hyperpigmentation. Laboratory workup shows elevated cortisol and high ACTH levels. The physician performs an HDDST, which demonstrates that the morning cortisol fails to suppress significantly after treatment. Based on these findings, what is the most likely underlying etiology of the patient’s Cushing's syndrome?

  • A) Adreninoma
  • B) Pituitary adenoma (Cushing's disease)
  • C) Ectopic ACTH production from SCLC
  • D) Primary adrenal insufficiency

Answer: C. Ectopic ACTH production from SCLC Explanation: The combination of high ACTH and skin hyperpigmentation is highly suggestive of an ACTH-dependent process, as ACTH shares a precursor molecule (POMC) with Melanocyte Stimulating Hormone (MSH). While both Cushing's disease (pituitary adenoma) and ectopic ACTH production are ACTH-dependent, the failure to suppress cortisol with high-dose dexamethasone strongly favors an ectopic source like SCLC over a pituitary adenoma.

Question 4 — Endocrinology

A patient is diagnosed with hypercortisolism. The physician notes that the patient has no skin hyperpigmentation and that both low-dose and high-dose dexamethasone fail to suppress cortisol levels. To definitively determine the cause, which of the following laboratory findings would be most helpful?

  • A) A significantly elevated plasma ACTH level
  • B) An adrenal adenoma confirmed by CT scan
  • C) A suppressed plasma ACTH level
  • D) Elevated 24-hour urinary free cortisol excretion

Answer: C. A suppressed plasma ACTH level Explanation: The absence of skin hyperpigmentation suggests an ACTH-independent cause. If the patient has high cortisol but a suppressed ACTH, it indicates that the adrenal gland is autonomously overproducing cortisol (e.g., adenoma). This autonomous production leads to negative feedback on the pituitary, suppressing ACTH. Therefore, finding a suppressed ACTH level confirms an ACTH-independent etiology, regardless of the non-suppression seen with dexamethasone.

Quick fire review

What key finding suggests Cushing's syndrome is ACTH-dependent?

Skin hyperpigmentation, because high ACTH levels are derived from POMC, which also yields MSH (melanocyte-stimulating hormone).

In an adreninoma causing Cushing's syndrome, what will the baseline ACTH level be?

Low/Suppressed, due to negative feedback exerted by the autonomously overproducing cortisol.

What is the primary limitation of using dexamethasone suppression testing?

It only works if the ACTH is elevated at baseline; it cannot suppress cortisol if ACTH is already suppressed.

Which type of Cushing's syndrome typically fails to suppress cortisol with high-dose dexamethasone, regardless of dose?

Ectopic ACTH production (e.g., SCLC) or Adreninoma (ACTH-independent).

What precursor molecule leads to the hyperpigmentation seen in ACTH-dependent Cushing's syndrome?

POMC (Proopiomelanocortin), which yields both ACTH and MSH.

If a patient has high cortisol but no skin hyperpigmentation, what is the most likely cause of their hypercortisolism?

An ACTH-independent source, such as an adreninoma.

What does finding elevated ACTH AND skin hyperpigmentation suggest in Cushing's syndrome workup?

ACTH-dependent etiology (e.g., pituitary adenoma or ectopic source).

Why is the HDDST ineffective for diagnosing adrenal adenomas?

Because the high cortisol from the adenoma causes negative feedback, suppressing baseline ACTH levels, leaving nothing for dexamethasone to suppress.

What specific finding differentiates Cushing's disease (pituitary) from SCLC-related ectopic ACTH production during an HDDST?

Cushing's disease typically shows suppression with high dose dexamethasone; SCLC usually does not suppress at all.

Name the precursor molecule that contains both melanocortin and opioid components, leading to hyperpigmentation when elevated.

POMC (Proopiomelanocortin).

If a patient has Cushing's syndrome with low ACTH and no skin changes, what is the most likely diagnosis?

Adreninoma (ACTH-independent cause).

Quick recall / Anki-style questions

What does finding elevated ACTH AND skin hyperpigmentation suggest in Cushing's syndrome workup?

ACTH-dependent etiology (e.g., pituitary adenoma or ectopic source).

Why is the HDDST ineffective for diagnosing adrenal adenomas?

Because the high cortisol from the adenoma causes negative feedback, suppressing baseline ACTH levels, leaving nothing for dexamethasone to suppress.

What specific finding differentiates Cushing's disease (pituitary) from SCLC-related ectopic ACTH production during an HDDST?

Cushing's disease typically shows suppression with high dose dexamethasone; SCLC usually does not suppress at all.

Name the precursor molecule that contains both melanocortin and opioid components, leading to hyperpigmentation when elevated.

POMC (Proopiomelanocortin).

If a patient has Cushing's syndrome with low ACTH and no skin changes, what is the most likely diagnosis?

Adreninoma (ACTH-independent cause).